Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Taylor

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Reply: Relevance of Measurement Uncertainty for Quantitative Response Assessment of Breast Cancer Bone Metastases with <sup>18</sup>F-FluorideGurdip Azad, Muhammad Siddique, Benjamin Taylor, et al.
Journal of Substance Abuse Treatment|April 24, 2012
Feasibility and impact of brief interventions for frequent cannabis users in CanadaBenedikt Fischer, Meghan Dawe, Fraser McGuire, et al.
Elife|March 21, 2017
A high-resolution map of transcriptional repressionZiwei Liang, Karen E Brown, Thomas Carroll, et al.
Resuscitation|February 23, 2023
Factors associated with the arrival of smartphone-activated first responders before the emergency medical services in Out-of-Hospital cardiac arrest dispatchLorenzo Gamberini, Donatella Del Giudice, Stefano Saltalamacchia, et al.
Military Medicine|October 18, 2025
From Combat to Search and Rescue: The Modern Air Force Pararescue Medical ExperienceRussell Day, Jason David, Erika Seagle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 26, 2018
Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of <sup>18</sup>F-Fluoride Metabolic Flux Than with Measurement of <sup>18</sup>F-Fluoride PET/CT SUV?Gurdip K Azad, Musib Siddique, Benjamin Taylor, et al.
JAMA Cardiology|October 4, 2017
Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor TherapyAnn Marie Navar, Benjamin Taylor, Hillary Mulder, et al.
Pharmacology, Biochemistry, and Behavior|April 6, 2007
The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotionLaurel M Pritchard, Amy Hauck Newman, Robert K McNamara, et al.
Radiology|May 9, 2017
Primary Rectal Cancer: Repeatability of Global and Local-Regional MR Imaging Texture FeaturesSofia Gourtsoyianni, Georgia Doumou, Davide Prezzi, et al.
Cardiovascular Drugs and Therapy|July 16, 2017
Primary Care Physician Perspectives on Barriers to Statin TreatmentRikki M Tanner, Monika M Safford, Keri L Monda, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Reply: Relevance of Measurement Uncertainty for Quantitative Response Assessment of Breast Cancer Bone Metastases with <sup>18</sup>F-FluorideGurdip Azad, Muhammad Siddique, Benjamin Taylor, et al.
Journal of Substance Abuse Treatment|April 24, 2012
Feasibility and impact of brief interventions for frequent cannabis users in CanadaBenedikt Fischer, Meghan Dawe, Fraser McGuire, et al.
Elife|March 21, 2017
A high-resolution map of transcriptional repressionZiwei Liang, Karen E Brown, Thomas Carroll, et al.
Resuscitation|February 23, 2023
Factors associated with the arrival of smartphone-activated first responders before the emergency medical services in Out-of-Hospital cardiac arrest dispatchLorenzo Gamberini, Donatella Del Giudice, Stefano Saltalamacchia, et al.
Military Medicine|October 18, 2025
From Combat to Search and Rescue: The Modern Air Force Pararescue Medical ExperienceRussell Day, Jason David, Erika Seagle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 26, 2018
Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of <sup>18</sup>F-Fluoride Metabolic Flux Than with Measurement of <sup>18</sup>F-Fluoride PET/CT SUV?Gurdip K Azad, Musib Siddique, Benjamin Taylor, et al.
JAMA Cardiology|October 4, 2017
Association of Prior Authorization and Out-of-pocket Costs With Patient Access to PCSK9 Inhibitor TherapyAnn Marie Navar, Benjamin Taylor, Hillary Mulder, et al.
Pharmacology, Biochemistry, and Behavior|April 6, 2007
The dopamine D3 receptor antagonist NGB 2904 increases spontaneous and amphetamine-stimulated locomotionLaurel M Pritchard, Amy Hauck Newman, Robert K McNamara, et al.
Radiology|May 9, 2017
Primary Rectal Cancer: Repeatability of Global and Local-Regional MR Imaging Texture FeaturesSofia Gourtsoyianni, Georgia Doumou, Davide Prezzi, et al.
Cardiovascular Drugs and Therapy|July 16, 2017
Primary Care Physician Perspectives on Barriers to Statin TreatmentRikki M Tanner, Monika M Safford, Keri L Monda, et al.
Pageof 10